Action ABCL ABCELLERA BIOLOGICS INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués AbCellera Biologics Inc.

Actions

ABCL

CA00288U1066

Marché Fermé - Nasdaq
Autres places de cotation
 22:00:00 06/06/2024 		Varia. 5j. Varia. 1 janv.
3,78 USD +0,80 % Graphique intraday de AbCellera Biologics Inc. -6,44 % -33,80 %
07/05 Transcript : AbCellera Biologics Inc., Q1 2024 Earnings Call, May 07, 2024
07/05 AbCellera Biologics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
BU
AbCellera Biologics : Corporate Overview
PU
AbCellera Biologics : Q1 2024 Business Update
PU
AbCellera Reports Q1 2024 Business Results
BU
AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies
BU
AbCellera Biologics : Corporate Overview
PU
AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024
BU
AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024
BU
AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024
BU
AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions
BU
AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024
BU
AbCellera Announces Resignation of Board Member
AQ
AbCellera Announces Resignation of Board Member
BU
AbCellera to Present at Upcoming Investor Conferences in March
BU
AbCellera Reports Full Year 2023 Business Results
BU
AbCellera to Report Full Year 2023 Financial Results on February 20, 2024
BU
AbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
BU
Cutting-edge antibody therapy firm, AbCellera, to lay off 10 per cent of workforce
AQ
AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023
BU
AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023
BU
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ABCL
  4. Actualités AbCellera Biologics Inc.
  5. Communiqués